Argos Therapeutics (FRA:77AA) Total Stockholders Equity : €-10.78 Mil (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Total Stockholders Equity?

Argos Therapeutics's Total Stockholders Equity for the quarter that ended in Sep. 2018 was €-10.78 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Argos Therapeutics's Book Value per Share for the quarter that ended in Sep. 2018 was €-1.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Argos Therapeutics's Debt-to-Equity for the quarter that ended in Sep. 2018 was -1.47.

Argos Therapeutics Total Stockholders Equity Historical Data

The historical data trend for Argos Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Total Stockholders Equity Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Total Stockholders Equity

Get a 7-Day Free Trial

-55.32

25.43

-25.89

5.85

-7.80

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Total Stockholders Equity	Get a 7-Day Free Trial															-14.24	-7.80	-2.58	-6.96	-10.78

Argos Therapeutics (FRA:77AA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Argos Therapeutics's Book Value per Share for the quarter that ended in Sep. 2018 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-10.775	-	0)	/	10.2248
	=	-1.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Argos Therapeutics's Debt-to-Equity for the quarter that ended in Sep. 2018 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.59	+	10.252)	/	-10.775
	=	-1.47

Argos Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines